| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
298 |
184 |
$707K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
58 |
25 |
$138K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,524 |
699 |
$119K |
| S9500 |
Home infusion therapy, antibiotic, antiviral, or antifungal therapy; once every 24 hours; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
1,279 |
224 |
$112K |
| 99601 |
|
2,318 |
915 |
$48K |
| S9379 |
Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
2,106 |
752 |
$28K |
| 96415 |
|
438 |
198 |
$6K |
| J2357 |
Injection, omalizumab, 5 mg |
20 |
14 |
$2K |
| S9338 |
Home infusion therapy, immunotherapy, administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
102 |
36 |
$2K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
114 |
40 |
$409.86 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
30 |
12 |
$10.02 |